Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Bronchial Thermoplasty Demonstrates Long-Term Asthma Control in Patients With Severe Asthma

November 2, 2010 5:33 am | by Boston Scientific | News | Comments

Two-year data presented at CHEST 2010 demonstrate ability of FDA-approved, non-drug asthma treatment to provide long-lasting symptom control

Baxa to Sponsor ASHP Midday Symposium - The Power of Control: Using Pharmacy Software Tools to get Control of your Workflow, Ensure Quality Control and Support Patient Safety ...

November 1, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

ENGLEWOOD, Colo., Nov. 1, 2010 /- Baxa Corporation , a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced its sponsorship of a customer forum at the 45th American Society of Health-System Pharmacists (ASHP)...

Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010

November 1, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Nov. 1, 2010 /- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will report results for its fiscal quarter ended September 30, 2010, on Tuesday, November 9, 2010 following the close of the U.S. financial markets.  As the Company recently...

Advertisement

Veroâ„¢ SBRT Unleashed

November 1, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 1 /- ASTRO, the annual meeting of the American Society for Therapeutic Radiology and Oncology, marks the introduction of Vero™ SBRT to the broader North American audience. The Vero SBRT system offers the latest in radiation technology: dynamic tumor tracking and...

CyberKnife Radiosurgery for Early-Stage Breast Cancer

October 31, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 31 /- Accuray Incorporated, (Nasdaq:  ARAY), a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of...

Surrogate decision makers wish to retain authority in difficult decision

October 29, 2010 4:35 pm | by EurekAlert | News | Comments

(American Thoracic Society) The decision to stop life-support for incapacitated and critically ill patients is, for surrogate decision makers, often fraught with moral and ethical uncertainty, and long-term emotional consequences. But as difficult as these decisions are, more than half of...

Allergy Update: Know your treatment options

October 29, 2010 4:34 pm | by Baylor College of Medicine | News | Comments

Allergies got you down? Dr. Madhu Narra , assistant professor of medicine in the section of allergy, immunology and rheumatology at Baylor College of Medicine discusses potential treatment options. Classic allergy symptoms include runny and itchy eyes and nose, sneezing, congestion,...

Accuray's CyberKnife VSI System Featured at 2010 American Society for Radiation Oncology (ASTRO) Annual Meeting

October 29, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that 40 accepted abstracts highlighting the use of the CyberKnife Robotic Radiosurgery System will be presented as posters and presentations at the 52nd Annual...

Advertisement

CyberKnife® VSI™ System Expands Treatment Applications and Significantly Reduces Treatment Times

October 29, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today feedback from Creekside Cancer Care on their use of the CyberKnife VSI System .  Creekside Cancer Care was the first facility in the world to install and...

Varian Medical Systems to Exhibit TrueBeam™ System for Image-Guided Cancer Treatments and New Software Capabilities at ASTRO Meeting in San Diego

October 28, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 28 /- ASTRO Booth # 201 -- Varian Medical Systems (NYSE: VAR ) will highlight its new TrueBeam™ system for fast, powerful and efficient cancer treatments at the 52nd annual meeting of the American Society for Radiation Oncology (ASTRO) meeting in San Diego next week....

Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

October 28, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology...

UM School of Medicine receives $45 million private donation for celiac research

October 28, 2010 8:32 am | by EurekAlert | News | Comments

(University of Maryland Medical Center) With a new $45 million private gift from the family of a grateful patient, the University of Maryland School of Medicine is planning to establish the nation's only major research enterprise devoted to the study of autoimmune and inflammatory...

Amira Pharmaceuticals Announces Initiation of Phase I Clinical Trial for AM152, A Novel LPA1 Antagonist

October 28, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 28 /- Amira Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study with AM152, a novel LPA1 antagonist, in normal, healthy subjects. "We are excited to begin our journey exploring the therapeutic value of AM152, a potentially novel...

Advertisement

Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call

October 28, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

CARY, N.C., Oct. 28 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today announced that it will host a conference call at 4:30 PM ET on Thursday, November 4, 2010, to discuss its financial results for the quarter and nine months ended September 30, 2010. Financial results are expected...

Boston Scientific Completes Acquisition of Asthmatx

October 26, 2010 1:31 pm | by Boston Scientific | News | Comments

NATICK, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Asthmatx, Inc. of Sunnyvale, California.  The transaction follows the definitive

Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphoma

October 25, 2010 5:33 pm | by EurekAlert | News | Comments

(American Society for Radiation Oncology) A lower dose of radiation used to reduce side effects is not as effective as the regular dose when given with the standard chemotherapy in the treatment of Hodgkin's lymphoma patients with early, intermediate-stage disease, according to a...

Plant stem cells could be fruitful source of low-cost cancer drug

October 25, 2010 1:32 pm | by EurekAlert | News | Comments

(University of Edinburgh) A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.

Allergies and wheezing illnesses in childhood may be determined in the womb

October 25, 2010 11:34 am | by EurekAlert | News | Comments

(University of Southampton) A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.

Discovery of taste receptors in the lungs could help people with asthma breathe easier

October 24, 2010 11:31 am | by EurekAlert | News | Comments

(University of Maryland Medical Center) Taste receptors in the lungs? Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the...

Studies: Pneumonia is misdiagnosed on patient readmissions

October 22, 2010 9:32 am | by EurekAlert | News | Comments

(Henry Ford Health System) Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results

October 22, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Oct. 22 /- Pharmaceutical company Pharmaxis (ASX: PXS) today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis. The combined results have been presented for the first...

Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h

October 21, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., Oct. 21 /- Actavis Inc. today announced a voluntary recall to the wholesale and retail levels only of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches manufactured for Actavis by Corium International in the United States. Actavis identified one lot of 25...

Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents

October 21, 2010 5:31 am | by Boston Scientific | News | Comments

Latest innovation in plastic biliary stent technology includes features for enhanced deliverability, efficiency and procedural control

New Choices for Colon Cancer Patients

October 20, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

SARASOTA, Fla., Oct. 20 /- Riley Powell taught high school English, and spent her summers training horses at a nearby dude ranch.  When she noticed blood in her stool, she thought it was hemorrhoids, from spending so many hours on horseback.  But when it persisted, she saw her...

New ratings of American hospitals released with quality study by HealthGrades

October 19, 2010 10:32 pm | by EurekAlert | News | Comments

(HealthGrades) A new independent study by HealthGrades of patient outcomes at America's hospitals found that patients at 5-star rated hospitals had a 72 percent lower risk of dying compared with patients at 1-star-rated hospitals -- an enormous gap that has held steady over the past years...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading